US5385707A
(en)
*
|
1988-12-28 |
1995-01-31 |
Stefan Miltenyi |
Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same
|
DE68919715T2
(de)
*
|
1988-12-28 |
1995-04-06 |
Stefan Miltenyi |
Verfahren sowie materialien zur hochgraduierten magnetischen abspaltung biologischer materialien.
|
US6020210A
(en)
*
|
1988-12-28 |
2000-02-01 |
Miltenvi Biotech Gmbh |
Methods and materials for high gradient magnetic separation of biological materials
|
US5622831A
(en)
*
|
1990-09-26 |
1997-04-22 |
Immunivest Corporation |
Methods and devices for manipulation of magnetically collected material
|
US5541072A
(en)
*
|
1994-04-18 |
1996-07-30 |
Immunivest Corporation |
Method for magnetic separation featuring magnetic particles in a multi-phase system
|
US5665582A
(en)
*
|
1990-10-29 |
1997-09-09 |
Dekalb Genetics Corp. |
Isolation of biological materials
|
AU8951191A
(en)
*
|
1990-10-29 |
1992-05-26 |
Dekalb Plant Genetics |
Isolation of biological materials using magnetic particles
|
US5370901A
(en)
*
|
1991-02-15 |
1994-12-06 |
Bracco International B.V. |
Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
US5186827A
(en)
*
|
1991-03-25 |
1993-02-16 |
Immunicon Corporation |
Apparatus for magnetic separation featuring external magnetic means
|
US6664114B1
(en)
|
1992-08-03 |
2003-12-16 |
Sapidyne Instruments, Inc. |
Solid phase assay for detection of ligands
|
AU2593192A
(en)
|
1992-09-14 |
1994-04-12 |
Oystein Fodstad |
Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
|
WO1994020855A1
(en)
*
|
1993-03-04 |
1994-09-15 |
Sapidyne, Inc. |
Assay flow apparatus and method
|
US5868257A
(en)
*
|
1993-05-07 |
1999-02-09 |
Carpco, Inc. |
Magnetic separation systems
|
GB9309446D0
(en)
*
|
1993-05-07 |
1993-06-23 |
Carpco Sms Ltd |
Improvements in and relating to super-conducting magnets
|
US5514340A
(en)
*
|
1994-01-24 |
1996-05-07 |
Magnetix Biotechnology, Inc. |
Device for separating magnetically labelled cells
|
NO180658C
(no)
|
1994-03-10 |
1997-05-21 |
Oeystein Fodstad |
Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
|
DE4416784A1
(de)
*
|
1994-05-09 |
1995-11-30 |
Soft Gene Gmbh |
Methode zur Anreicherung von Zellen, die durch ballistischen Transfer modifiziert wurden
|
US5705059A
(en)
*
|
1995-02-27 |
1998-01-06 |
Miltenyi; Stefan |
Magnetic separation apparatus
|
DE19516323C2
(de)
*
|
1995-04-27 |
1997-02-27 |
Dirk Dipl Chem Guenther |
Verfahren zur Herstellung von magnetisierbaren Dispersionen und deren Verwendung
|
DE19520298A1
(de)
*
|
1995-06-02 |
1996-12-05 |
Bayer Ag |
Sortiervorrichtung für biologische Zellen oder Viren
|
US5639669A
(en)
*
|
1995-06-07 |
1997-06-17 |
Ledley; Robert |
Separation of fetal cells from maternal blood
|
US5741714A
(en)
*
|
1995-07-18 |
1998-04-21 |
Immunivest Corporation |
Detection of bound analyte by magnetic partitioning and masking
|
DE19528029B4
(de)
|
1995-07-31 |
2008-01-10 |
Chemagen Biopolymer-Technologie Aktiengesellschaft |
Magnetische Polymerpartikel auf der Basis von Polyvinylalkohol, Verfahren für ihre Herstellung und Verwendung
|
US6190870B1
(en)
|
1995-08-28 |
2001-02-20 |
Amcell Corporation |
Efficient enrichment and detection of disseminated tumor cells
|
US6140040A
(en)
*
|
1995-10-06 |
2000-10-31 |
Advanced Minerals Corporation |
Method of mechanically separating microparticles suspended in fluids using particulate media
|
NO961031D0
(no)
|
1996-03-13 |
1996-03-13 |
Det Norske Radiumshospital Tum |
Fremgangsmåte til å drepe uönskede målceller
|
DE19612001A1
(de)
*
|
1996-03-18 |
1997-09-25 |
Silica Gel Gmbh Adsorptions Te |
Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung
|
US6455678B1
(en)
|
1996-04-26 |
2002-09-24 |
Amcell Corporation |
Human hematopoietic stem and progenitor cell antigen
|
US5843633A
(en)
*
|
1996-04-26 |
1998-12-01 |
Amcell Corporation |
Characterization of a human hematopoietic progenitor cell antigen
|
US7666308B2
(en)
*
|
1996-06-07 |
2010-02-23 |
Veridex, Llc. |
Magnetic separation apparatus and methods
|
US6890426B2
(en)
*
|
1996-06-07 |
2005-05-10 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
US6790366B2
(en)
*
|
1996-06-07 |
2004-09-14 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
US6660159B1
(en)
|
1996-06-07 |
2003-12-09 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
US5993665A
(en)
*
|
1996-06-07 |
1999-11-30 |
Immunivest Corporation |
Quantitative cell analysis methods employing magnetic separation
|
US6136182A
(en)
*
|
1996-06-07 |
2000-10-24 |
Immunivest Corporation |
Magnetic devices and sample chambers for examination and manipulation of cells
|
IL128057A
(en)
*
|
1996-08-05 |
2001-08-26 |
Schering Ag |
Process for the production of contrast media
|
US5817458A
(en)
*
|
1996-10-15 |
1998-10-06 |
The Avriel Group, Amcas Division Inc. |
Reagent system for detecting HIV-infected peripheral blood lymphocytes in whole blood
|
EP0933989A1
(de)
*
|
1996-10-15 |
1999-08-11 |
Bio-Tech Imaging, Inc. |
Reagenzsystem und ausrüstung zur erkennung hiv-infizierter zellen
|
US5779892A
(en)
*
|
1996-11-15 |
1998-07-14 |
Miltenyi Biotec Gmbh |
Magnetic separator with magnetic compensated release mechanism for separating biological material
|
US5798206A
(en)
*
|
1997-01-10 |
1998-08-25 |
New York Blood Center |
Methods for screening of test compounds for inhibiting binding of a CD4-HIV 1 complex to a chemokine receptor
|
FR2758884B1
(fr)
|
1997-01-30 |
1999-04-02 |
Bio Merieux |
Procede pour isoler, notamment detecter ou quantifier un analyte dans un milieu
|
US6241894B1
(en)
|
1997-10-10 |
2001-06-05 |
Systemix |
High gradient magnetic device and method for cell separation or purification
|
CA2260991C
(en)
|
1997-11-18 |
2009-03-24 |
Bio-Rad Laboratories, Inc. |
Multiplex flow immunoassays with magnetic particles as solid phase
|
US6337215B1
(en)
*
|
1997-12-01 |
2002-01-08 |
International Business Machines Corporation |
Magnetic particles having two antiparallel ferromagnetic layers and attached affinity recognition molecules
|
EP0941766B1
(de)
|
1998-03-12 |
2006-12-20 |
Miltenyi Biotec GmbH |
Mikrokolonnen-System für Magnettrennung
|
US7220596B2
(en)
|
1998-04-15 |
2007-05-22 |
Utah State University |
Real time detection of antigens
|
JP4601166B2
(ja)
|
1998-05-11 |
2010-12-22 |
ミルテニィ バイオテック ゲーエムベーハー |
抗原特異的t細胞の直接的選択方法
|
ES2313800T3
(es)
*
|
1998-11-30 |
2009-03-01 |
Veridex, Llc |
Aparato y procedimiento de separacion magnetica.
|
US7364921B1
(en)
|
1999-01-06 |
2008-04-29 |
University Of Medicine And Dentistry Of New Jersey |
Method and apparatus for separating biological materials and other substances
|
US6159378A
(en)
*
|
1999-02-23 |
2000-12-12 |
Battelle Memorial Institute |
Apparatus and method for handling magnetic particles in a fluid
|
US6193892B1
(en)
|
1999-03-03 |
2001-02-27 |
Promega Corporation |
Magnetic separation assembly and method
|
EP1177424A4
(de)
|
1999-04-09 |
2005-04-06 |
Shot Inc |
Elektromagnetisches mehrphasen-trenngerät zur reinigung von zellen, chemikalien und protein-strukturen
|
DE19938372A1
(de)
*
|
1999-08-09 |
2001-03-08 |
Diagnostikforschung Inst |
Verfahren und Vorrichtung zur Trennung magnetischer Teilchen
|
JP4612982B2
(ja)
|
1999-09-03 |
2011-01-12 |
ミルテニィ バイオテック ゲーエムベーハー |
磁性細胞分離カラムにおける選択された細胞の改変方法
|
US7169618B2
(en)
|
2000-06-28 |
2007-01-30 |
Skold Technology |
Magnetic particles and methods of producing coated magnetic particles
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
ATE349011T1
(de)
*
|
2000-10-03 |
2007-01-15 |
Minerva Biotechnologies Corp |
Magnetisches in situ dilutionsverfahren
|
US6649419B1
(en)
*
|
2000-11-28 |
2003-11-18 |
Large Scale Proteomics Corp. |
Method and apparatus for protein manipulation
|
FR2817967B1
(fr)
*
|
2000-12-08 |
2003-02-28 |
Diagast |
Procede de magnetisation de marqueurs chimiques ou biologiques
|
US20030095897A1
(en)
*
|
2001-08-31 |
2003-05-22 |
Grate Jay W. |
Flow-controlled magnetic particle manipulation
|
DE60233248D1
(de)
|
2001-11-15 |
2009-09-17 |
Childrens Medical Center |
Verfahren zur isolierung, expansion und differenzierung fötaler stammzellen aus chorionzotte, fruchtwasser und plazenta und therapeutische verwendungen davon
|
US20030099954A1
(en)
*
|
2001-11-26 |
2003-05-29 |
Stefan Miltenyi |
Apparatus and method for modification of magnetically immobilized biomolecules
|
US7232691B2
(en)
*
|
2001-11-27 |
2007-06-19 |
Los Alamos National Security, Llc |
Bioassay and biomolecular identification, sorting, and collection methods using magnetic microspheres
|
AU2002359648A1
(en)
*
|
2001-12-07 |
2003-06-23 |
Dyax Corporation |
Method and apparatus for washing magnetically responsive particles
|
US7514270B2
(en)
*
|
2002-04-12 |
2009-04-07 |
Instrumentation Laboratory Company |
Immunoassay probe
|
US9435799B2
(en)
*
|
2002-07-31 |
2016-09-06 |
Janssen Diagnostics, Inc. |
Methods and reagents for improved selection of biological materials
|
US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
EP1540348A4
(de)
|
2002-08-27 |
2006-10-11 |
Stemcells California Inc |
Angereicherte stammzellen- und vorläuferzellpopulationen des zentralen nervensystems und identifizierungs-, isolierungs- und anreicherungsverfahren für solche populationen
|
DE10331439B3
(de)
|
2003-07-10 |
2005-02-03 |
Micromod Partikeltechnologie Gmbh |
Magnetische Nanopartikel mit verbesserten Magneteigenschaften
|
US7601491B2
(en)
*
|
2003-02-06 |
2009-10-13 |
Becton, Dickinson And Company |
Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
|
DE112004002408B4
(de)
*
|
2003-12-10 |
2008-04-30 |
University Of Utah Research Foundation, Salt Lake City |
Verfahren zur Gewinnung einer angereicherten Population von siRNA-exprimierenden Zellen
|
WO2005065267A2
(en)
*
|
2003-12-24 |
2005-07-21 |
Massachusetts Institute Of Technology |
Magnetophoretic cell clarification
|
US8211386B2
(en)
*
|
2004-06-08 |
2012-07-03 |
Biokit, S.A. |
Tapered cuvette and method of collecting magnetic particles
|
US9790539B2
(en)
*
|
2004-06-30 |
2017-10-17 |
Russell Biotech, Inc. |
Methods and reagents for improved selection of biological molecules
|
US20060024776A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Mcmillian Ray |
Magnetic particle capture of whole intact organisms from clinical samples
|
WO2006017427A1
(en)
*
|
2004-08-03 |
2006-02-16 |
Becton, Dickinson And Company |
Use of magnetic material to fractionate samples
|
WO2006112771A1
(en)
*
|
2005-04-18 |
2006-10-26 |
Ge Healthcare Bio-Sciences Ab |
Magnetic beads
|
WO2007079149A2
(en)
*
|
2005-12-28 |
2007-07-12 |
The General Hospital Corporation |
Blood cell sorting methods and systems
|
US7862813B2
(en)
|
2006-07-29 |
2011-01-04 |
Bjork Jr Robert Lamar |
Bi-specific monoclonal antibody (specific for both CD3 and CD11b) therapeutic drug
|
US8168393B2
(en)
|
2007-02-16 |
2012-05-01 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods for diagnosing tumors using LEDGF/p75
|
DE102007043281A1
(de)
|
2007-09-11 |
2009-05-28 |
Sebastian Dr. med. Chakrit Bhakdi |
Vorrichtung, Materialien und Verfahren zur Hochgradientenmagnetseparation biologischen Materials
|
EP2193146B1
(de)
|
2007-09-14 |
2016-05-25 |
Adimab, LLC |
Synthetische antikörperbibliotheken mit rationalem design und ihre verwendung
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
ES2640216T3
(es)
|
2007-12-07 |
2017-11-02 |
Miltenyi Biotec Gmbh |
Sistemas y métodos para procesamiento de células
|
US8338170B2
(en)
|
2008-04-21 |
2012-12-25 |
Viacyte, Inc. |
Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
|
DK2727998T3
(da)
|
2008-04-21 |
2019-08-26 |
Viacyte Inc |
Fremgangsmåder til oprensning af pancreatiske endodermceller afledt fra humane embryoniske stamceller
|
US20110177592A1
(en)
*
|
2008-07-11 |
2011-07-21 |
Faustman Denise L |
Magnetic apparatus for blood separation
|
EP2356227B1
(de)
|
2008-11-14 |
2018-03-28 |
Viacyte, Inc. |
Einkapselung von aus menschlichen pluripotenten stammzellen abgeleiteten pankreaszellen
|
US20100158878A1
(en)
|
2008-12-23 |
2010-06-24 |
Alexandra Capela |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
GB0823553D0
(en)
|
2008-12-24 |
2009-01-28 |
Immunosolv Ltd |
Cell separation technique
|
US8790916B2
(en)
*
|
2009-05-14 |
2014-07-29 |
Genestream, Inc. |
Microfluidic method and system for isolating particles from biological fluid
|
WO2011007310A1
(en)
|
2009-07-17 |
2011-01-20 |
Koninklijke Philips Electronics N.V. |
Apparatus for the enrichment of magnetic particles
|
US8083069B2
(en)
*
|
2009-07-31 |
2011-12-27 |
General Electric Company |
High throughput magnetic isolation technique and device for biological materials
|
TWI362964B
(en)
*
|
2009-12-23 |
2012-05-01 |
Ind Tech Res Inst |
Magnetic separation device and method for separating magnetic substances in bio-samples
|
EP2390661B1
(de)
|
2010-05-02 |
2015-06-24 |
Miltenyi Biotec GmbH |
Verankerungs-/Erfassungsmittel zum Auswählen oder Analysieren einer CHO-Zelle entsprechend einem Produkt, das von der CHO-Zelle sezerniert wird
|
DE102011015321A1
(de)
|
2011-03-28 |
2012-10-04 |
Ralph Heindrichs |
Verfahren zur kontinuierlichen selektiven Separation von Partikeln mittels Magnetismus
|
US9494557B2
(en)
|
2011-04-05 |
2016-11-15 |
Purdue Research Foundation |
Micro-fluidic system using micro-apertures for high throughput detection of cells
|
TWI407101B
(zh)
|
2011-04-11 |
2013-09-01 |
Ind Tech Res Inst |
磁分離單元、磁性分離裝置以及分離生化試樣內磁性物質之方法
|
US9885642B2
(en)
|
2011-04-27 |
2018-02-06 |
Becton, Dickinson And Company |
Devices and methods for separating magnetically labeled moieties in a sample
|
ES2602500T3
(es)
|
2011-11-25 |
2017-02-21 |
Miltenyi Biotec Gmbh |
Método de separación celular
|
ES2616289T3
(es)
|
2012-03-01 |
2017-06-12 |
Miltenyi Biotec Gmbh |
Separación de neuronas vivas intactas
|
DE102012213032A1
(de)
*
|
2012-07-25 |
2014-01-30 |
Siemens Aktiengesellschaft |
Verfahren zum Entwässern einer wasserhaltigen Zellkultur
|
DK2890498T3
(en)
|
2012-08-29 |
2018-05-22 |
Inguran Llc |
MAGNETIC REMOVAL OR IDENTIFICATION OF DAMAGED OR COMPRIMATED CELLS OR CELL STRUCTURES
|
US10379026B2
(en)
|
2012-08-29 |
2019-08-13 |
Inguran, Llc |
Cell processing using magnetic particles
|
CN110595987A
(zh)
|
2012-10-26 |
2019-12-20 |
贝克顿·迪金森公司 |
用于操纵流体样品中的组分的装置和方法
|
EP2787006B1
(de)
|
2013-04-02 |
2018-02-28 |
Miltenyi Biotec GmbH |
Anti-CD8 Antikörper mit kalziumabhängiger Bindung
|
US9884326B2
(en)
*
|
2013-06-28 |
2018-02-06 |
National Institute Of Advanced Industrial Science And Technology |
Matrix for magnetic separator and magnetic separator
|
CN113046312A
(zh)
|
2014-04-23 |
2021-06-29 |
朱诺治疗学股份有限公司 |
分离、培养和遗传工程改造用于过继治疗的免疫细胞群的方法
|
JP2017521091A
(ja)
|
2014-05-15 |
2017-08-03 |
ケルベンクス インコーポレイテッド |
診断試験用の胎児有核赤血球(nrbc)の調製
|
EP2955521A1
(de)
|
2014-06-11 |
2015-12-16 |
Centre Hospitalier Universitaire Vaudois (CHUV) |
Verfahren zur Trennung von Zellen
|
MA40253A
(fr)
|
2014-07-15 |
2017-05-24 |
Juno Therapeutics Inc |
Cellules modifiées pour thérapie cellulaire adoptive
|
TWI751102B
(zh)
|
2014-08-28 |
2022-01-01 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
ES2879612T3
(es)
|
2014-10-20 |
2021-11-22 |
Juno Therapeutics Inc |
Métodos y composiciones para dosificación en terapia celular adoptiva
|
MA40318A
(fr)
|
2014-11-05 |
2017-09-13 |
Juno Therapeutics Inc |
Procédés de transduction et de traitement de cellules
|
MX2017007138A
(es)
|
2014-12-03 |
2017-08-28 |
Juno Therapeutics Inc |
Metodos y composiciones para terapia celular adoptiva.
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
US20160208018A1
(en)
|
2015-01-16 |
2016-07-21 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for ror1
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
CA2986060A1
(en)
|
2015-05-29 |
2016-12-08 |
Valerie Odegard |
Composition and methods for regulating inhibitory interactions in genetically engineered cells
|
MA42895A
(fr)
|
2015-07-15 |
2018-05-23 |
Juno Therapeutics Inc |
Cellules modifiées pour thérapie cellulaire adoptive
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
CN116875635A
(zh)
|
2015-10-22 |
2023-10-13 |
朱诺治疗学有限公司 |
用于转导的方法、反应剂盒、反应剂和设备
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
US11020429B2
(en)
|
2015-11-05 |
2021-06-01 |
Juno Therapeutics, Inc. |
Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy
|
MA44314A
(fr)
|
2015-11-05 |
2018-09-12 |
Juno Therapeutics Inc |
Récepteurs chimériques contenant des domaines induisant traf, et compositions et méthodes associées
|
US10625272B2
(en)
|
2015-11-18 |
2020-04-21 |
Industrial Technology Research Institute |
Magnetic separator
|
AU2016363025B2
(en)
|
2015-12-03 |
2021-04-08 |
Juno Therapeutics, Inc. |
Modified chimeric receptors and related compositions and methods
|
MA43378A
(fr)
|
2015-12-03 |
2018-10-10 |
Juno Therapeutics Inc |
Compositions et méthodes pour la reduction de la réponse immunitaire contre récepteurs d'antigène chimériques
|
MA43377A
(fr)
|
2015-12-04 |
2021-05-19 |
Hutchinson Fred Cancer Res |
Méthodes et compositions liées à la toxicité associée à la thérapie cellulaire
|
CN108601731A
(zh)
|
2015-12-16 |
2018-09-28 |
磨石肿瘤生物技术公司 |
新抗原的鉴别、制造及使用
|
EP3430548A1
(de)
|
2016-03-16 |
2019-01-23 |
Juno Therapeutics, Inc. |
Verfahren zur bestimmung der dosierung eines therapeutikums und verwandte behandlungen
|
EP3430549A1
(de)
|
2016-03-16 |
2019-01-23 |
Juno Therapeutics, Inc. |
Verfahren zum adaptiven design eines behandlungsplans und ähnlicher behandlungen
|
EP4015536A1
(de)
|
2016-03-22 |
2022-06-22 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
Frühinterventionsverfahren zur vermeidung oder verbesserung von toxizität
|
CA3026453A1
(en)
|
2016-06-03 |
2017-12-07 |
Memorial Sloan-Kettering Cancer Center |
Adoptive cell therapies as early treatment options
|
MA45341A
(fr)
|
2016-06-06 |
2019-04-10 |
Hutchinson Fred Cancer Res |
Procédés de traitement de malignités de lymphocytes b au moyen d'une thérapie cellulaire adoptive
|
CA3028002A1
(en)
|
2016-06-27 |
2018-01-04 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
ES2926513T3
(es)
|
2016-07-29 |
2022-10-26 |
Juno Therapeutics Inc |
Métodos para evaluar la presencia o ausencia de virus competente en replicación
|
MX2019001185A
(es)
|
2016-07-29 |
2019-10-21 |
Juno Therapeutics Inc |
Polipeptidos inmunomoduladores y composiciones y metodos relacionados.
|
CN110088133B
(zh)
|
2016-07-29 |
2023-12-08 |
朱诺治疗学股份有限公司 |
抗独特型抗体及相关方法
|
EP3957997A1
(de)
|
2016-08-26 |
2022-02-23 |
Juno Therapeutics, Inc. |
Verfahren zur zählung von partikeln in einer zellzusammensetzung
|
CA3035829A1
(en)
|
2016-09-12 |
2018-03-15 |
Juno Therapeutics, Inc. |
Perfusion bioreactor bag assemblies
|
CN110139873A
(zh)
|
2016-10-03 |
2019-08-16 |
朱诺治疗学股份有限公司 |
Hpv特异性结合分子
|
US11896615B2
(en)
|
2016-10-13 |
2024-02-13 |
Juno Therapeutics, Inc. |
Immunotherapy methods and compositions involving tryptophan metabolic pathway modulators
|
US20190292246A1
(en)
|
2016-11-03 |
2019-09-26 |
Juno Therapeutics, Inc. |
Combination therapy of a cell based therapy and a microglia imhibitor
|
WO2018085731A2
(en)
|
2016-11-03 |
2018-05-11 |
Juno Therapeutics, Inc. |
Combination therapy of a t cell therapy and a btk inhibitor
|
CN110494565A
(zh)
|
2016-12-02 |
2019-11-22 |
朱诺治疗学股份有限公司 |
工程化b细胞及相关组合物和方法
|
MA46995A
(fr)
|
2016-12-03 |
2019-10-09 |
Acerta Pharma Bv |
Méthodes et compositions pour l'utilisation de lymphocytes t thérapeutiques en association avec des inhibiteurs de kinase
|
US20200078400A1
(en)
|
2016-12-03 |
2020-03-12 |
Juno Therapeutics, Inc. |
Methods for determining car-t cells dosing
|
CA3045508A1
(en)
|
2016-12-03 |
2018-06-07 |
Juno Therapeutics, Inc. |
Methods for modulation of car-t cells
|
JP2019536461A
(ja)
|
2016-12-05 |
2019-12-19 |
ジュノー セラピューティクス インコーポレイテッド |
養子細胞療法のための操作細胞の産生
|
AU2018207305A1
(en)
|
2017-01-10 |
2019-07-25 |
Juno Therapeutics, Inc. |
Epigenetic analysis of cell therapy and related methods
|
CN110418802A
(zh)
|
2017-01-20 |
2019-11-05 |
朱诺治疗学有限公司 |
细胞表面缀合物及相关的细胞组合物和方法
|
CA3052779A1
(en)
|
2017-02-17 |
2018-08-23 |
Fred Hutchinson Cancer Research Center |
Combination therapies for treatment of bcma-related cancers and autoimmune disorders
|
BR112019017767A2
(pt)
|
2017-02-27 |
2020-04-07 |
Juno Therapeutics Inc |
composições, artigos de fabricação e métodos relacionados à dosagem em terapia celular
|
AU2018234640B2
(en)
|
2017-03-14 |
2024-03-14 |
Juno Therapeutics, Inc. |
Methods for cryogenic storage
|
WO2018187791A1
(en)
|
2017-04-07 |
2018-10-11 |
Juno Therapeutics, Inc |
Engineered cells expressing prostate-specific membrane antigen (psma) or a modified form thereof and related methods
|
AU2018251188A1
(en)
|
2017-04-14 |
2019-10-31 |
Juno Therapeutics, Inc. |
Methods for assessing cell surface glycosylation
|
BR112019022356A2
(pt)
|
2017-04-27 |
2020-05-26 |
Juno Therapeutics Gmbh |
Reagentes de partícula oligoméricos e métodos de uso dos mesmos
|
CA3061945A1
(en)
|
2017-05-01 |
2018-11-08 |
Juno Therapeutics, Inc. |
Combination of a cell therapy and an immunomodulatory compound
|
MA48781A
(fr)
|
2017-06-02 |
2020-04-08 |
Juno Therapeutics Inc |
Articles de fabrication et procédés liés à la toxicité associée à la thérapie cellulaire
|
WO2018223101A1
(en)
|
2017-06-02 |
2018-12-06 |
Juno Therapeutics, Inc. |
Articles of manufacture and methods for treatment using adoptive cell therapy
|
EP3638774A1
(de)
|
2017-06-14 |
2020-04-22 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Verfahren zur reinigung von endodermen und pankreatischen endodermen zellen aus menschlichen embryonalen stammzellen
|
WO2018231373A1
(en)
*
|
2017-06-14 |
2018-12-20 |
Russell Biotech, Inc. |
Preparation of platelet free mononuclear cells
|
JP2020526194A
(ja)
|
2017-06-29 |
2020-08-31 |
ジュノー セラピューティクス インコーポレイテッド |
免疫療法薬と関連する毒性を評価するためのマウスモデル
|
BR112020001719A2
(pt)
|
2017-07-29 |
2020-07-21 |
Juno Therapeutics Inc |
reagentes para expansão de células que expressam receptores recombinantes
|
ES2959953T3
(es)
|
2017-08-09 |
2024-02-29 |
Juno Therapeutics Inc |
Métodos para producir composiciones celulares genéticamente modificadas y composiciones relacionadas
|
BR112020001601A2
(pt)
|
2017-08-09 |
2020-08-11 |
Juno Therapeutics Inc |
métodos e composições para preparar células geneticamente manipuladas
|
MA50057A
(fr)
|
2017-09-01 |
2020-07-08 |
Juno Therapeutics Inc |
Expression génique et évaluation d'un risque de développement d'une toxicité suite à une thérapie cellulaire
|
WO2019051335A1
(en)
|
2017-09-07 |
2019-03-14 |
Juno Therapeutics, Inc. |
METHODS OF IDENTIFYING CELLULAR CHARACTERISTICS RELATED TO RESPONSES ASSOCIATED WITH CELL THERAPY
|
CA3080546A1
(en)
|
2017-10-03 |
2019-04-11 |
Juno Therapeutics, Inc. |
Hpv-specific binding molecules
|
KR20200087143A
(ko)
|
2017-10-10 |
2020-07-20 |
그릿스톤 온콜로지, 인코포레이티드 |
핫스팟을 이용한 신생항원 동정
|
WO2019089848A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods associated with tumor burden for assessing response to a cell therapy
|
MA50855A
(fr)
|
2017-11-01 |
2020-09-09 |
Juno Therapeutics Inc |
Procédé de génération de compositions thérapeutiques de cellules modifiées
|
SG11202003657VA
(en)
|
2017-11-01 |
2020-05-28 |
Juno Therapeutics Inc |
Process for producing a t cell composition
|
WO2019089858A2
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods of assessing or monitoring a response to a cell therapy
|
KR20200116077A
(ko)
|
2017-11-01 |
2020-10-08 |
주노 쎄러퓨티크스 인코퍼레이티드 |
B 세포 성숙 항원에 특이적인 키메라 항원 수용체 및 암호화 폴리뉴클레오타이드
|
CA3080904A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for b-cell maturation antigen
|
WO2019090364A1
(en)
|
2017-11-06 |
2019-05-09 |
Juno Therapeutics, Inc. |
Combination of a cell therapy and a gamma secretase inhibitor
|
WO2019094835A1
(en)
|
2017-11-10 |
2019-05-16 |
Juno Therapeutics, Inc. |
Closed-system cryogenic vessels
|
CA3083097A1
(en)
|
2017-11-22 |
2019-05-31 |
Gritstone Oncology, Inc. |
Reducing junction epitope presentation for neoantigens
|
CN111989106A
(zh)
|
2017-12-01 |
2020-11-24 |
朱诺治疗学股份有限公司 |
基因工程化细胞的给药和调节方法
|
KR20200109308A
(ko)
|
2017-12-08 |
2020-09-22 |
주노 쎄러퓨티크스 인코퍼레이티드 |
세포 요법을 위한 표현형 마커 및 관련 방법
|
MX2020005908A
(es)
|
2017-12-08 |
2020-10-07 |
Juno Therapeutics Inc |
Proceso para producir una composicion de celulas t modificadas.
|
BR112020011144A2
(pt)
|
2017-12-08 |
2020-11-17 |
Juno Therapeutics Inc |
formulação de meio livre de soro para o cultivo de células e métodos de uso da mesma
|
EP3724225A1
(de)
|
2017-12-15 |
2020-10-21 |
Juno Therapeutics, Inc. |
Anti-cct5-bindende moleküle und verfahren zur verwendung davon
|
JP2021511802A
(ja)
|
2018-01-31 |
2021-05-13 |
ジュノー セラピューティクス インコーポレイテッド |
複製可能ウイルスの存在または非存在を評価するための方法および試薬
|
JP7383620B2
(ja)
|
2018-01-31 |
2023-11-20 |
セルジーン コーポレイション |
養子細胞療法およびチェックポイント阻害剤を使用する併用療法
|
WO2019169194A1
(en)
|
2018-02-28 |
2019-09-06 |
Juno Therapeutics, Inc. |
Methods for detecting particles present in a cell composition
|
WO2019170845A1
(en)
|
2018-03-09 |
2019-09-12 |
Ospedale San Raffaele S.R.L. |
Il-1 antagonist and toxicity induced by cell therapy
|
MX2020010461A
(es)
|
2018-04-05 |
2021-01-15 |
Juno Therapeutics Inc |
Linfocitos t que expresan un receptor recombinante, polinucleotidos y metodos relacionados.
|
CN112566698A
(zh)
|
2018-04-05 |
2021-03-26 |
朱诺治疗学股份有限公司 |
T细胞受体和表达该t细胞受体的工程化细胞
|
EP3775238A1
(de)
|
2018-04-05 |
2021-02-17 |
Juno Therapeutics, Inc. |
Verfahren zur herstellung von zellen, die einen rekombinanten rezeptor exprimieren, und verwandte zusammensetzungen
|
CA3098497A1
(en)
|
2018-05-03 |
2019-11-07 |
Juno Therapeutics, Inc. |
Combination therapy of a chimeric antigen receptor (car) t cell therapy and a kinase inhibitor
|
EP3807305A4
(de)
|
2018-06-13 |
2022-04-20 |
Akron Biotechnology, LLC |
Verfahren zur herstellung von therapeutisch wirksamem aldesleukin, das in flüssigen pharmazeutischen zusammensetzungen hochstabil ist
|
US20210230671A1
(en)
|
2018-08-09 |
2021-07-29 |
Juno Therapeutics, Inc. |
Methods for assessing integrated nucleic acids
|
US20210163893A1
(en)
|
2018-08-09 |
2021-06-03 |
Juno Therapeutics, Inc. |
Processes for generating engineered cells and compositions thereof
|
CA3110905A1
(en)
|
2018-08-31 |
2020-03-05 |
Invectys SA |
Chimeric antigen receptors against multiple hla-g isoforms
|
CN113167796A
(zh)
|
2018-09-11 |
2021-07-23 |
朱诺治疗学股份有限公司 |
对工程化细胞组合物进行质谱分析的方法
|
WO2020092848A2
(en)
|
2018-11-01 |
2020-05-07 |
Juno Therapeutics, Inc. |
Methods for treatment using chimeric antigen receptors specific for b-cell maturation antigen
|
WO2020092854A2
(en)
|
2018-11-01 |
2020-05-07 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (gprc5d)
|
EP3877054B1
(de)
|
2018-11-06 |
2023-11-01 |
Juno Therapeutics, Inc. |
Verfahren zur herstellung von genetisch veränderten t-zellen
|
AU2019377854A1
(en)
|
2018-11-08 |
2021-05-27 |
Juno Therapeutics, Inc. |
Methods and combinations for treatment and T cell modulation
|
JP2022513062A
(ja)
|
2018-11-16 |
2022-02-07 |
ジュノー セラピューティクス インコーポレイテッド |
B細胞悪性腫瘍を処置するために、操作されたt細胞を投薬する方法
|
JP2022513685A
(ja)
|
2018-11-30 |
2022-02-09 |
ジュノー セラピューティクス インコーポレイテッド |
養子細胞療法を用いた処置のための方法
|
MX2021006244A
(es)
|
2018-11-30 |
2021-09-10 |
Juno Therapeutics Inc |
Metodos de dosificacion y tratamiento de canceres de celulas b en terapia celular adoptiva.
|
PE20212198A1
(es)
|
2019-01-29 |
2021-11-16 |
Juno Therapeutics Inc |
Anticuerpos y receptores quimericos de antigenos especificos para receptor 1 huerfano tipo receptor tirosina-cinasa (ror1)
|
EP3693739A1
(de)
|
2019-02-06 |
2020-08-12 |
Stefan Schreier |
Verfahren und vorrichtung zur isolierung von gewünschten zellen aus einer probe nicht-magnetischer biologischer materialien
|
AU2020265741A1
(en)
|
2019-05-01 |
2021-11-25 |
Editas Medicine, Inc. |
Cells expressing a recombinant receptor from a modified TGFBR2 Locus, related polynucleotides and methods
|
MX2021013223A
(es)
|
2019-05-01 |
2022-02-17 |
Juno Therapeutics Inc |
Celulas que expresan un receptor quimerico de un locus cd247 modificado, polinucleotidos relacionados y metodos.
|
US20230258663A9
(en)
|
2019-05-02 |
2023-08-17 |
Kellbenx Incorporated |
Filtration-based methods for preparing fetal nucleated red blood cells (nrbcs) for diagnostic testing
|
US20220249637A1
(en)
|
2019-06-12 |
2022-08-11 |
Juno Therapeutics, Inc. |
Combination therapy of a cell-mediated cytotoxic therapy and an inhibitor of a prosurvival bcl2 family protein
|
WO2021035194A1
(en)
|
2019-08-22 |
2021-02-25 |
Juno Therapeutics, Inc. |
Combination therapy of a t cell therapy and an enhancer of zeste homolog 2 (ezh2) inhibitor and related methods
|
WO2021041994A2
(en)
|
2019-08-30 |
2021-03-04 |
Juno Therapeutics, Inc. |
Machine learning methods for classifying cells
|
WO2021092097A1
(en)
|
2019-11-05 |
2021-05-14 |
Juno Therapeutics, Inc. |
Methods of determining attributes of therapeutic t cell compositions
|
US20220401483A1
(en)
|
2019-11-07 |
2022-12-22 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and (s)-3-[4-(4-morpholin-4-ylmethyl-benzyloxy)-l-oxo-l,3-dihydro-isoindol-2-yl]-piperidine-2,6-dione
|
WO2021113780A1
(en)
|
2019-12-06 |
2021-06-10 |
Juno Therapeutics, Inc. |
Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods
|
JP2023504737A
(ja)
|
2019-12-06 |
2023-02-06 |
ジュノー セラピューティクス インコーポレイテッド |
B細胞性悪性疾患を処置するための細胞療法と関連する毒性および奏効に関係する方法
|
JP2023504740A
(ja)
|
2019-12-06 |
2023-02-06 |
ジュノー セラピューティクス インコーポレイテッド |
Bcma標的結合ドメインに対する抗イディオタイプ抗体ならびに関連する組成物および方法
|
AU2021209940A1
(en)
|
2020-01-24 |
2022-08-04 |
Juno Therapeutics, Inc. |
Methods for dosing and treatment of follicular lymphoma and marginal zone lymphoma in adoptive cell therapy
|
WO2021154887A1
(en)
|
2020-01-28 |
2021-08-05 |
Juno Therapeutics, Inc. |
Methods for t cell transduction
|
EP4103204A1
(de)
|
2020-02-12 |
2022-12-21 |
Juno Therapeutics, Inc. |
Cd19-gerichtete chimäre antigen-rezeptor-t-zell-zusammensetzungen und verfahren und verwendungen davon
|
JP2023519099A
(ja)
|
2020-02-12 |
2023-05-10 |
ジュノー セラピューティクス インコーポレイテッド |
Bcma指向性キメラ抗原受容体t細胞組成物ならびにその方法および使用
|
KR20230009386A
(ko)
|
2020-04-10 |
2023-01-17 |
주노 쎄러퓨티크스 인코퍼레이티드 |
B-세포 성숙 항원을 표적화하는 키메라 항원 수용체로 조작된 세포 요법 관련 방법 및 용도
|
EP4142723A2
(de)
|
2020-04-28 |
2023-03-08 |
Juno Therapeutics, Inc. |
Kombination aus bcma-gerichteter t-zelltherapie und einer immunmodulatorischen verbindung
|
JP2023528215A
(ja)
|
2020-05-13 |
2023-07-04 |
ジュノー セラピューティクス インコーポレイテッド |
臨床応答に関連する特徴量の特定方法およびその使用
|
KR20230022868A
(ko)
|
2020-05-13 |
2023-02-16 |
주노 쎄러퓨티크스 인코퍼레이티드 |
재조합 수용체를 발현하는 공여자-배치 세포의 제조 방법
|
WO2021260186A1
(en)
|
2020-06-26 |
2021-12-30 |
Juno Therapeutics Gmbh |
Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methods
|
EP4192868A1
(de)
|
2020-08-05 |
2023-06-14 |
Juno Therapeutics, Inc. |
Antiidiotypische antikörper gegen ror1-gerichtete bindungsdomänen und zugehörige zusammensetzungen und verfahren
|
WO2022098787A1
(en)
|
2020-11-04 |
2022-05-12 |
Juno Therapeutics, Inc. |
Cells expressing a chimeric receptor from a modified invariant cd3 immunoglobulin superfamily chain locus and related polynucleotides and methods
|
WO2022133030A1
(en)
|
2020-12-16 |
2022-06-23 |
Juno Therapeutics, Inc. |
Combination therapy of a cell therapy and a bcl2 inhibitor
|
CN117693508A
(zh)
|
2021-03-03 |
2024-03-12 |
朱诺治疗学股份有限公司 |
T细胞疗法和dgk抑制剂的组合
|
KR20230159851A
(ko)
|
2021-03-22 |
2023-11-22 |
주노 쎄러퓨티크스 인코퍼레이티드 |
치료 세포 조성물의 효력을 결정하는 방법
|
WO2022212400A1
(en)
|
2021-03-29 |
2022-10-06 |
Juno Therapeutics, Inc. |
Methods for dosing and treatment with a combination of a checkpoint inhibitor therapy and a car t cell therapy
|
WO2022212384A1
(en)
|
2021-03-29 |
2022-10-06 |
Juno Therapeutics, Inc. |
Combination of a car t cell therapy and an immunomodulatory compound for treatment of lymphoma
|
KR20230171468A
(ko)
|
2021-04-16 |
2023-12-20 |
셀진 코포레이션 |
Bcma-지시된 t 세포 요법과의 조합 요법
|
WO2023081735A1
(en)
|
2021-11-03 |
2023-05-11 |
Celgene Corporation |
Chimeric antigen receptors specific for b-cell maturation antigen for use in treating myeloma
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
WO2023147515A1
(en)
|
2022-01-28 |
2023-08-03 |
Juno Therapeutics, Inc. |
Methods of manufacturing cellular compositions
|
WO2023164440A1
(en)
|
2022-02-22 |
2023-08-31 |
Juno Therapeutics, Inc. |
Proteinase 3 (pr3) chimeric autoantibody receptor t cells and related methods and uses
|
WO2023220655A1
(en)
|
2022-05-11 |
2023-11-16 |
Celgene Corporation |
Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
|
WO2023230548A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Method for predicting response to a t cell therapy
|
WO2023230581A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Methods of manufacturing t cell therapies
|
WO2023250400A1
(en)
|
2022-06-22 |
2023-12-28 |
Juno Therapeutics, Inc. |
Treatment methods for second line therapy of cd19-targeted car t cells
|
WO2024006960A1
(en)
|
2022-06-29 |
2024-01-04 |
Juno Therapeutics, Inc. |
Lipid nanoparticles for delivery of nucleic acids
|
WO2024031091A2
(en)
|
2022-08-05 |
2024-02-08 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for gprc5d and bcma
|
WO2024044779A2
(en)
|
2022-08-26 |
2024-02-29 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for delta-like ligand 3 (dll3)
|
WO2024054944A1
(en)
|
2022-09-08 |
2024-03-14 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and continuous or intermittent dgk inhibitor dosing
|